MTEM News and Press, Molecular Templates Inc. From 07/13/23

2023-07-13 09:09:03 ET Molecular Templates ( NASDAQ: MTEM ) plans to conduct a private placement offering of securities to raise up to $40 million, the company said Thursday. Certain healthcare investors participating in the offering will purchase an initial tranche of $20 mil...

AUSTIN, Texas, July 13, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineer...

Restructuring agreement with K2 HealthVentures (K2HV) to fully discharge and satisfy outstanding debt owed to K2HV for the prepayment of $27.5 million and the granting of contingent value rights and warrants Additional reduction-in-force by approximately 44% as it continues to exp...

AUSTIN, Texas, June 01, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineer...

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineere...

2023-05-15 16:59:19 ET Molecular Templates press release ( NASDAQ: MTEM ): Q1 GAAP EPS of $0.19. Revenue of $36.6M (+330.6% Y/Y). For further details see: Molecular Templates GAAP EPS of $0.19, revenue of $36.6M

Advancing clinical development of MT-6402, MT-8421, and MT-0169, and preclinical activities related to Bristol Myers Squibb collaboration AUSTIN, Texas, May 15, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM ...

AUSTIN, Texas, April 07, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), today announced that the U.S. Food and Drug Administration (the “FDA”) informed MTEM that it has placed a partial clini...

2023-04-05 11:48:12 ET What are penny stocks? This is probably a question you’re asking if you’re brand new to the stock market. The basic definition includes stocks trading for less than $5 and are typically associated with smaller start-up companies. However, that doesn ...

2023-03-31 03:46:54 ET Molecular Templates press release ( NASDAQ: MTEM ): Q4 GAAP EPS of -$0.39 misses by $0.09 . Revenue of $2.6M (-85.6% Y/Y) misses by $6.21M . As of December 31, 2022, MTEM’s cash and investments totaled $61.0M. For further det...